302 related articles for article (PubMed ID: 25262802)
21. Binding of N-terminal fragments of anthrax edema factor (EF(N)) and lethal factor (LF(N)) to the protective antigen pore.
Leuber M; Kronhardt A; Tonello F; Dal Molin F; Benz R
Biochim Biophys Acta; 2008 Jun; 1778(6):1436-43. PubMed ID: 18243126
[TBL] [Abstract][Full Text] [Related]
22. Bacillus anthracis: a multi-faceted role for anthrax lethal toxin in thwarting host immune defenses.
Xu L; Frucht DM
Int J Biochem Cell Biol; 2007; 39(1):20-4. PubMed ID: 17008119
[TBL] [Abstract][Full Text] [Related]
23. Exceptionally Selective Substrate Targeting by the Metalloprotease Anthrax Lethal Factor.
Turk BE
Adv Exp Med Biol; 2019; 1111():189-203. PubMed ID: 30267305
[TBL] [Abstract][Full Text] [Related]
24. Small molecule inhibitors of anthrax lethal factor toxin.
Williams JD; Khan AR; Cardinale SC; Butler MM; Bowlin TL; Peet NP
Bioorg Med Chem; 2014 Jan; 22(1):419-34. PubMed ID: 24290062
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosides.
Lee LV; Bower KE; Liang FS; Shi J; Wu D; Sucheck SJ; Vogt PK; Wong CH
J Am Chem Soc; 2004 Apr; 126(15):4774-5. PubMed ID: 15080670
[TBL] [Abstract][Full Text] [Related]
26. Lethal factor, but not edema factor, is required to cause fatal anthrax in cynomolgus macaques after pulmonary spore challenge.
Hutt JA; Lovchik JA; Drysdale M; Sherwood RL; Brasel T; Lipscomb MF; Lyons CR
Am J Pathol; 2014 Dec; 184(12):3205-16. PubMed ID: 25285720
[TBL] [Abstract][Full Text] [Related]
27. Zeptomole per milliliter detection and quantification of edema factor in plasma by LC-MS/MS yields insights into toxemia and the progression of inhalation anthrax.
Lins RC; Boyer AE; Kuklenyik Z; Woolfitt AR; Goldstein J; Hoffmaster AR; Gallegos-Candela M; Leysath CE; Chen Z; Brumlow JO; Quinn CP; Bagarozzi DA; Leppla SH; Barr JR
Anal Bioanal Chem; 2019 May; 411(12):2493-2509. PubMed ID: 30911800
[TBL] [Abstract][Full Text] [Related]
28. Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy.
Sherer K; Li Y; Cui X; Eichacker PQ
Am J Respir Crit Care Med; 2007 Feb; 175(3):211-21. PubMed ID: 17095744
[TBL] [Abstract][Full Text] [Related]
29. Anthrax lethal factor cleaves regulatory subunits of phosphoinositide-3 kinase to contribute to toxin lethality.
Mendenhall MA; Liu S; Portley MK; O'Mard D; Fattah R; Szabo R; Bugge TH; Khillan JS; Leppla SH; Moayeri M
Nat Microbiol; 2020 Dec; 5(12):1464-1471. PubMed ID: 32895527
[TBL] [Abstract][Full Text] [Related]
30. Patent prospects toward therapeutics and diagnostics of anthrax.
Chauhan R; Wadhwa G; Sharma SK; Jain CK
Recent Pat Antiinfect Drug Discov; 2014; 9(1):52-61. PubMed ID: 25145329
[TBL] [Abstract][Full Text] [Related]
31. Lethal factor of anthrax toxin binds monomeric form of protective antigen.
Chvyrkova I; Zhang XC; Terzyan S
Biochem Biophys Res Commun; 2007 Aug; 360(3):690-5. PubMed ID: 17617379
[TBL] [Abstract][Full Text] [Related]
32. Anthrax toxin: pathologic effects on the cardiovascular system.
Golden HB; Watson LE; Lal H; Verma SK; Foster DM; Kuo SR; Sharma A; Frankel A; Dostal DE
Front Biosci (Landmark Ed); 2009 Jan; 14(6):2335-57. PubMed ID: 19273204
[TBL] [Abstract][Full Text] [Related]
33. Computational insights into the interaction of the anthrax lethal factor with the N-terminal region of its substrates.
Joshi M; Ebalunode JO; Briggs JM
Proteins; 2009 May; 75(2):323-35. PubMed ID: 18831046
[TBL] [Abstract][Full Text] [Related]
34. Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers.
Feld GK; Thoren KL; Kintzer AF; Sterling HJ; Tang II; Greenberg SG; Williams ER; Krantz BA
Nat Struct Mol Biol; 2010 Nov; 17(11):1383-90. PubMed ID: 21037566
[TBL] [Abstract][Full Text] [Related]
35. Cross-inhibition between furin and lethal factor inhibitors.
Peinado JR; Kacprzak MM; Leppla SH; Lindberg I
Biochem Biophys Res Commun; 2004 Aug; 321(3):601-5. PubMed ID: 15358148
[TBL] [Abstract][Full Text] [Related]
36. Anthrax toxin: the long and winding road that leads to the kill.
Abrami L; Reig N; van der Goot FG
Trends Microbiol; 2005 Feb; 13(2):72-8. PubMed ID: 15680766
[TBL] [Abstract][Full Text] [Related]
37. Involvement of domain II in toxicity of anthrax lethal factor.
Liang X; Young JJ; Boone SA; Waugh DS; Duesbery NS
J Biol Chem; 2004 Dec; 279(50):52473-8. PubMed ID: 15465830
[TBL] [Abstract][Full Text] [Related]
38. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W
Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174
[TBL] [Abstract][Full Text] [Related]
39. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
[TBL] [Abstract][Full Text] [Related]
40. High-sensitivity MALDI-TOF MS quantification of anthrax lethal toxin for diagnostics and evaluation of medical countermeasures.
Boyer AE; Gallegos-Candela M; Quinn CP; Woolfitt AR; Brumlow JO; Isbell K; Hoffmaster AR; Lins RC; Barr JR
Anal Bioanal Chem; 2015 Apr; 407(10):2847-58. PubMed ID: 25673244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
